BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31775891)

  • 1. Ovarian cancer detection by DNA methylation in cervical scrapings.
    Wu TI; Huang RL; Su PH; Mao SP; Wu CH; Lai HC
    Clin Epigenetics; 2019 Nov; 11(1):166. PubMed ID: 31775891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
    Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
    J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.
    Liew PL; Huang RL; Wu TI; Liao CC; Chen CW; Su PH; Wang HC; Weng YC; Lai HC
    Clin Epigenetics; 2019 Nov; 11(1):170. PubMed ID: 31779688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings.
    Huang RL; Su PH; Liao YP; Wu TI; Hsu YT; Lin WY; Wang HC; Weng YC; Ou YC; Huang TH; Lai HC
    Clin Cancer Res; 2017 Jan; 23(1):263-272. PubMed ID: 27507616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
    Wu JH; Liang XA; Wu YM; Li FS; Dai YM
    Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time colorimetric detection of DNA methylation of the
    Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
    Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
    Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
    Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
    Terp SK; Stoico MP; Dybkær K; Pedersen IS
    Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.
    Wang R; van Leeuwen RW; Boers A; Klip HG; de Meyer T; Steenbergen RD; van Criekinge W; van der Zee AG; Schuuring E; Wisman GB
    Oncotarget; 2016 Dec; 7(49):80735-80750. PubMed ID: 27738327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of ovarian cancer using plasma cell-free DNA methylomes.
    Lu H; Liu Y; Wang J; Fu S; Wang L; Huang C; Li J; Xie L; Wang D; Li D; Zhou H; Rao Q
    Clin Epigenetics; 2022 Jun; 14(1):74. PubMed ID: 35681212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor Lesions.
    Pisanic TR; Cope LM; Lin SF; Yen TT; Athamanolap P; Asaka R; Nakayama K; Fader AN; Wang TH; Shih IM; Wang TL
    Clin Cancer Res; 2018 Dec; 24(24):6536-6547. PubMed ID: 30108103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
    Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
    Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms.
    Huang RL; Chang CC; Su PH; Chen YC; Liao YP; Wang HC; Yo YT; Chao TK; Huang HC; Lin CY; Chu TY; Lai HC
    PLoS One; 2012; 7(7):e41060. PubMed ID: 22815913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
    Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
    Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
    Liang L; Zhang Y; Li C; Liao Y; Wang G; Xu J; Li Y; Yuan G; Sun Y; Zhang R; Li X; Nian W; Zhao J; Zhang Y; Zhu X; Wen X; Cai S; Li N; Wu L
    EBioMedicine; 2022 Sep; 83():104222. PubMed ID: 35973389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
    Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
    Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.
    Widschwendter M; Zikan M; Wahl B; Lempiäinen H; Paprotka T; Evans I; Jones A; Ghazali S; Reisel D; Eichner J; Rujan T; Yang Z; Teschendorff AE; Ryan A; Cibula D; Menon U; Wittenberger T
    Genome Med; 2017 Dec; 9(1):116. PubMed ID: 29268796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of DNA demethylation on the upregulation of the NRN1 and TNFAIP3 genes associated with advanced gastric cancer.
    Wisnieski F; Santos LC; Calcagno DQ; Geraldis JC; Gigek CO; Anauate AC; Chen ES; Rasmussen LT; Payão SLM; Artigiani R; Demachki S; Assumpção PP; Lourenço LG; Arasaki CH; Pabinger S; Krainer J; Leal MF; Burbano RR; Arruda Cardoso Smith M
    J Mol Med (Berl); 2020 May; 98(5):707-717. PubMed ID: 32285140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.